Cramer Gives His Opinion On Cardiff Oncology, Lemonade And More

On CNBC's "Mad Money Lightning Round," Jim Cramer said Cardiff Oncology Inc CRDF is "just okay." He thinks it is a very speculative situation.

Atomera Inc ATOM is also very speculative, believes Cramer. He would rather buy NVIDIA Corporation NVDA.

Why investors prefer Lemonade Inc LMND over Root Inc ROOT is a mystery, Cramer said. He thinks Lemonade is terrific but that its separation from Root is simply a matter of being more popular in the "Wall Street fashion show."

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Small CapMediaTrading IdeasCNBCJim Cramermad money Lightning Round
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!